ADAR1 Capital Management Reports Acquisition of $1,434.84 in InMed Pharmaceuticals Common Shares
Bitget2026/10/20 21:32- ADAR1 Capital Management purchased 1,087 InMed Pharmaceuticals common shares at $1.32 each.
- Indirect beneficial ownership rose to 956,580 common shares.
- Daniel Schneeberger, ADAR1's manager, is also listed as a 10% owner.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS cuts around 200 positions in London as Credit Suisse integration enters final stage
UBS has recently implemented a new round of staff reductions in London, cutting around 200 positions over the past few weeks. The bank's integration of Credit Suisse is nearing completion.
Wall Street veteran Yardeni: Cooling inflation is expected, 5% US Treasury bonds are "very attractive"
Ed Yardeni, President of Yardeni Research, stated that with inflation expected to cool down, the yield on the 10-year US Treasury at around 5% looks "very attractive."
Euro: Positive outlook hinges on 1.1280 against US Dollar - UOB
USD/JPY Price Forecast: Remains close to 20-day EMA
Crypto prices
More
